Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 31Neoplasms 6Breast Neoplasms 6Prostatic Neoplasms, Castration-Resistant 4Pancreatic Neoplasms 4Neoplasm Metastasis 4Metastatic Castration Resistant Prostate Cancer 4Colorectal Neoplasms 3Triple Negative Breast Neoplasms 2Prostate Adenocarcinoma 2Urinary Bladder Neoplasms 1Urinary Bladder Diseases 1Urethral Neoplasms 1Ureteral Neoplasms 1Ureteral Diseases 1Thrombocytosis 1Solid Tumours 1Solid Tumor 1Small Cell Lung Carcinoma 1Recurrence 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pharmacokinetics of MDV3100 1Pathologic Complete Response 1Ovarian Neoplasms 1Neoplasms, Squamous Cell 1Neoplasm, Residual 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1

Interventions

pembrolizumab 3blinatumomab 2enzalutamide 1durvalumab 1dostarlimab 1cemiplimab 1atezolizumab 1abiraterone 1N,N-dicyclohexyl-isoborneol-10-sulfonamide 1Immune Checkpoint Inhibitors 1Hydroxyurea 1Etoposide 1Etanercept 1Cytochrome P-450 Enzyme System 1Carboplatin 1AMG 757 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Bites and Stings × enzalutamide × Clear all
NCT04221542 2026-05-29

Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer

Amgen

Phase 1 Recruiting
479 enrolled
Genitourinary

Bites and Stings, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡